Commercializing the Stem Cell Sciences (Biohealthcare Publishing Series on Pharma, Biotech and Bioscience: Science Technology)

Last Updated on Saturday, 9 July 2011 09:25 Written by Administrator Saturday, 9 July 2011 09:25

Commercializing the Stem Cell Sciences (Biohealthcare Publishing Series on Pharma, Biotech and Bioscience: Science Technology)

This book offers a comparative analysis of the commercial models adopted in the global stem cell industries, focusing on case-studies of publicly available information about different companies around the world working on adapting stem cell technologies to market. The case-studies are used to highlight the different possible pipelines for developing stem cell technologies and the issues faced by companies in the competitive global market. Promising new developments in biomedical technology like stem cell science are widely endorsed by governments keen to reduce spiralling healthcare costs, clinicians focused on patient care and patients demanding revolutionary new treatments. The intersections between governments, healthcare settings and community demand are the environment in which companies are operating to secure a profit in a global marketplace. The key questions posed by this book include: Is there an optimum commercial model? And what can emerging companies learn from their predecessors? Extant research on the global stem cell bioeconomy has highlighted the ways that culture, ethics and national politics have influenced and shaped the commercial possibilities for companies entering into the stem cell market and what possibilities exist for negotiating these barriers. Key issues for commercialization in particular include raising money to conduct research, dealing with regulatory frameworks, developing an intellectual property portfolio, testing technologies in animals and patients, and securing market share. This book explores these issues in examining the future commercial development of the stem cell sciences. Each chapter includes in-depth discussion of case-studies of products undergoing development and the pathways to market that are being adopted. Explicitly focused on the question of commercial optimization, this project is the first of its kind to move beyond concerns about ethics and regulation to examine how products are actually being developed for market. The analysis is considered within a global context, with case-studies being drawn from a diverse range of countries that are commercialising stem cell products. This book features a strong comparative element in order to facilitate a focus on best practice within varied national contexts. Unlike other projects in the field that are focused on human applications only, this book includes discussion of non-human applications of stem cell therapies because this is one of the fastest growing commercial markets to date, and translation of successful products from animal uses to human uses is currently an revolutionary growth area.

List Price: $ 165.00

Price: $ 165.00

Share and Enjoy:

Site Search

Commercializing the Stem Cell Sciences (Biohealthcare Publishing Series on Pharma, Biotech and Bioscience: Science Technology)